Sanwal Mehta in Jackson, Tennessee

Home Tennessee Jackson

Sanwal Mehta has Critical Care (intensivists) as his primary medical specialty. Their primary office is: 620 Skyline Dr in Jackson, Tennessee.

They're a part of the: West Tennessee Healthcare Hospitalists Inc medical group which has around 80 members. You can call their office at 731-541-4923 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2016 (around 8 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Sanwal S Mehta Office Phone and Directions

Sanwal Mehta
West Tennessee Healthcare Hospitalists Inc
620 Skyline Dr
Jackson, Tennessee 38301
731-541-4923

Patient Ratings
Please rate your experience with Sanwal Mehta below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 731-541-4923

Enter a starting address:

Healthcare Info for Sanwal Mehta

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2016
The Primary Medical Specialty for Sanwal Mehta is listed as: Critical Care (intensivists)
Approximate Years of Experience: 8
PAC (PECOS ID)#: 2163767484
NPI #: 1740701655
NPI Created On: 06/30/2017
NPI Last Updated Listed as: 07/27/2023
Primary Taxonomy Code: 390200000X
Listed Gender: Male

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829486819

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: LOKELMA

Open Associated Drug #1: 0310-1105-30